Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Triple Negative Breast Neoplasms 3Breast Neoplasms 2

Interventions

Specimen Handling 317Magnetic Resonance Spectroscopy 275pembrolizumab 268Carboplatin 190Cyclophosphamide 182Biopsy 175Cisplatin 164Gemcitabine 139Paclitaxel 137Bevacizumab 122fludarabine 119Nivolumab 115Radiotherapy 114Oxaliplatin 96venetoclax 94Fluorouracil 90Docetaxel 87Dexamethasone 86Capecitabine 86Drug Therapy 76Rituximab 74Pemetrexed 72Leucovorin 71durvalumab 70Radiosurgery 69Blood Specimen Collection 69Standard of Care 68Doxorubicin 64atezolizumab 62Radiation 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × famitinib × 90 days × Clear all
NCT05582499 2026-05-28

FASCINATE-N

Fudan University

Phase 2 Recruiting
716 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05749588 2026-04-16

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Fudan University

Phase 2 Recruiting
120 enrolled
Breast

Triple Negative Breast Neoplasms

NCT06649331 2026-04-08

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Fudan University

Phase 2 Recruiting
160 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡